From Name:
From Email:
To Name:
To Email:

Optional Message:


Study: New melanoma drug doubles survival time

from CBS News

Advanced melanoma is often considered a death sentence, since patients will live only 6 to 10 months by the time it's diagnosed. A new study of a recently approved drug called vemurafenib offers hope, because it nearly doubled life expectancy of patients with metastatic melanoma to 16 months. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063